Navigation Links
Kalorama: Antibiotic Drug Resistance Leads to HAI Deaths
Date:8/13/2014

NEW YORK, Aug. 13, 2014 /PRNewswire/ -- Antibiotic drug resistance is considered to play a part in 75,000 hospital acquired infection (HAI) deaths per year in the U.S., according to recent analysis by Kalorama Information. The healthcare market research publisher found that drug resistance is becoming more of an issue across the entire anti-infective continuum, despite indications that screening patients in the hospital would help to identify those patients that may be carriers of multi-drug resistant organisms.

Kalorama Information, in its report Healthcare Infection Control Market, notes that patients, third party payers, and tax payers through Medicare and Medicaid payments shoulder the added expense of hospital infections -- an estimated $35-40 billion in costs each year in the U.S. The report can be found at: http://www.marketresearch.com/redirect.asp?progid=86511&url=http%3A%2F%2Fwww%2Ekaloramainformation%2Ecom%2FHealthcare%2DAssociated%2DInfection%2D8143524%2F

"Hospital acquired infections erode hospital profits, which can limit the services and care provided to patients," report analyst Melissa Elder related. "Costs from infections at the hospital level are often not completely covered by a payer, leading to a negative impact on the bottom line of hospitals, which further strengthens the need to reduce HAIs."

According to Elder, Indirect costs include lost worker productivity/wages, psychological damages, mortality, and change in social function. Direct hospital costs include labor, building overhead, damages payment, utilities, staffing, consultations, treatment, therapy, devices, supplies, equipment, medications, and food.

The resistance to drugs is considered a natural response to the selective pressure of drug therapy. Although this is a natural course, the effects of resistance can be amplified or accelerated by several other factors including: abuse or misuse of anti-infectives; poor quality of drugs available (most common in underdeveloped regions); poor patient compliance and reduced course of treatment due to cost constraints.

In the CDC Guidelines for Isolation Precautions in Hospitals, the Hospital Infection Control Practices Advisory Committee noted that transmission of infections requires a source, a host and actual transmission. According to the guidelines, the most frequent mode of transmission is direct surface contact and physical transfer of microorganisms between a susceptible host and an infected or colonized person. "Infection intervention programs have long stressed direct contact precautions but have not adequately addressed direct body surface to body surface contact," noted Elder.

According to the report, HAIs are currently being addressed through an annual provision in the Affordable Care Act (ACA).  The ACA allows funding for each state which participates in improving HAI prevention infrastructures or implementing new infrastructure measures. During 2013, the U.S. provided more than $11 million in state funding for HAI prevention infrastructure projects and development.  

Healthcare Infection Control Market notes the issues and trends affecting the infection control market and provides information regarding leading competitors in that market. The report can be found along with other industry leading research from Kalorama Information at: http://www.kaloramainformation.com/.

About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Contact:
Bruce Carlson
bcarlson@kaloramainformation.com 
www.KaloramaInformation.com  
212.807.2622 t
240.747.3004 f

Logo - http://photos.prnewswire.com/prnh/20140801/132634


'/>"/>
SOURCE Kalorama Information
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Kalorama: Billion-dollar Plus Market for Flow Cytometry Used in Clinical Testing
2. Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT)
3. Applegate CEO Worries FDA Plan To Address Antibiotics In Animal Agriculture Is Too Little, Too Late
4. FDA starts process to cut back antibiotic overuse in livestock
5. AVMA lauds FDA for new regulation of antibiotics in livestock feed
6. MGB Biopharma Adds its Support to European Antibiotic Awareness Day
7. Las nuevas guías recomiendan fidaxomicina para todos los pacientes aptos para el tratamiento con antibióticos orales contra la infección por clostridium difficile
8. Scientists at HerbalScience Develop a Synergistic Method to Fight Antibiotic Resistant Bacteria
9. CDC Report Shows Growing Threat Posed By Antibiotic Resistance
10. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
11. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):